Limited official informationFDA Drug Enforcement ReportsRecall date: Apr 22, 2026

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

1Is my item affected?

Compare the complete identifiers. Name similarity alone is not a confirmed match.

Affected variants from the official event record
Product or model	Codes and lots	Quantity	Recall number
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR	Lot Number [email protected]	91 vials	D-0471-2026

The agency's statement is shown without a site-authored severity score.

Lack of Assurance of Sterility

Agency classification: Class II

Only instructions associated with this recall event qualify as an action.

Consumer action is not available in the associated official record. The site does not infer or generate a replacement.

The linked agency record controls if any information differs.

Official scope

Distribution is context, not a confirmed item match. Compare the model, lot, UPC, NDC, or serial number above.

No material affected-item, risk, action, or status change has been recorded since this page entered the tracker.